NCT03466658

Brief Summary

The objective of the study is to evaluate the efficacy of preoperative treatment with a novel, wireless, low-level microcurrent-generating antimicrobial device (brand name: JumpStart) in preventing the spread of Propionibacterium acnes in patients receiving open or arthroscopic shoulder surgery.

Trial Health

57
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
17

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Nov 2018

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
terminated

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

March 9, 2018

Completed
6 days until next milestone

First Posted

Study publicly available on registry

March 15, 2018

Completed
8 months until next milestone

Study Start

First participant enrolled

November 1, 2018

Completed
9 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

August 1, 2019

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

August 1, 2019

Completed
5 months until next milestone

Results Posted

Study results publicly available

January 6, 2020

Completed
Last Updated

January 6, 2020

Status Verified

December 1, 2019

Enrollment Period

9 months

First QC Date

March 9, 2018

Results QC Date

November 22, 2019

Last Update Submit

January 2, 2020

Conditions

Outcome Measures

Primary Outcomes (1)

  • Presence of Propionibacterium Acnes in Skin Biopsies During Surgery

    The primary outcome measures the intraoperative culture results (e.g. positive vs negative, days to positive conversion) for P. acnes by evaluating bacterial cultures from punch skin biopsies at the time of the surgery.

    7 days post-biopsy

Study Arms (2)

JumpStart group

EXPERIMENTAL

This group will have the JumpStart dressing pre-operatively. Intervention: JumpStart dressing

Device: JumpStart Antimicrobial Wound Dressing

Control group

NO INTERVENTION

This group will have no intervention pre-operatively. Intervention: none

Interventions

A novel, wireless, low-level microcurrent-generating antimicrobial device (JumpStart) is a sterile single layer dressing consisting of a matrix of alternating silver (Ag) and zinc (Zn) dots that are held in positions on a polyester substrate with biocompatible binder. Dressing is then activated in the presence of a conductive fluid, which may come from wound exudate or exogenous fluids, such as saline. It has been observed, in vitro, to exhibit electricidal effect in the presence of antibiotic and multidrug resistant clinical wound isolates.

JumpStart group

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • years old or older
  • Scheduled to receive open or arthroscopic shoulder surgery

You may not qualify if:

  • years old or younger
  • Pregnant women
  • Prisoners
  • Non-English speaking or unable to understand consent
  • History of any prior shoulder surgery
  • History of previous shoulder infection or clinical signs of preoperative infection
  • History of taking any antibiotic(s) within 4 weeks prior to the scheduled shoulder surgery
  • Active acne or skin inflammatory disorders (psoriasis, eczema, etc) in the shoulder

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Penn State Bone and Joint Institute

Hershey, Pennsylvania, 17033, United States

Location

Results Point of Contact

Title
Dr. Hyunmin Kim
Organization
Penn State Health

Study Officials

  • Hyunmin Kim, MD

    Penn State Bone and Joint Institute

    PRINCIPAL INVESTIGATOR

Publication Agreements

PI is Sponsor Employee
Yes

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
PREVENTION
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
MD

Study Record Dates

First Submitted

March 9, 2018

First Posted

March 15, 2018

Study Start

November 1, 2018

Primary Completion

August 1, 2019

Study Completion

August 1, 2019

Last Updated

January 6, 2020

Results First Posted

January 6, 2020

Record last verified: 2019-12

Data Sharing

IPD Sharing
Will not share

Locations